LIBERTY GLUCOSE CONTROL, MODEL 2120031— 510(k) K052980

Clearance details

Applicant

Liberty Healthcare Group, Inc.

Product code

Code JJX

Device class

Class 1

Regulation

21 CFR 862.1660

Advisory panel

Clinical Chemistry

Date received

2005-10-24

Decision date

2005-11-30

Decision

Substantially Equivalent

Clearance type

Traditional

Location

Seguin, TX, US

• K170678 — Beta-CrossLaps CalCheck 52017-04-04
• K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
• K162514 — Multichem A1c2016-10-26
• K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
• K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

• K063855 — LIBERTY NORMAL GLUCOSE CONTROL SOLUTION, MODEL 2120045/ HIGH GLUCOSE CONTROL SOLUTION, MODEL 21200472007-02-01
• K060706 — LIBERTY NORMAL GLUCOSE CONTROL SOLUTION2006-04-28
• K060426 — LIBERTY GLUCOSE NORMAL CONTROL SOLUTIONS, MODEL 21200412006-03-09
• K060481 — LIBERTY GLUCOSE CONTROL SOLUTION2006-03-09

Other

2

Total

2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →